Cargando…
Comparable long-term outcomes between upfront haploidentical and identical sibling donor transplant in aplastic anemia: a national registry-based study
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains a curative option for severe aplastic anemia (SAA), and transplantation from identical sibling donors (ISD) has been recommended as a first-line treatment. Haploidentical donor (HID) transplantation for SAA has made great advance...
Autores principales: | Xu, Zheng-Li, Xu, Lan-Ping, Wu, De-Pei, Wang, Shun-Qing, Zhang, Xi, Xi, Rui, Gao, Su-Jun, Xia, Ling-Hui, Yang, Jian-Min, Jiang, Ming, Wang, Xin, Liu, Qi-Fa, Chen, Jia, Zhou, Ming, Huang, Xiao-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713560/ https://www.ncbi.nlm.nih.gov/pubmed/35615930 http://dx.doi.org/10.3324/haematol.2022.280758 |
Ejemplares similares
-
Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant
por: Xu, Lan-Ping, et al.
Publicado: (2017) -
Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study
por: Xu, Lan-Ping, et al.
Publicado: (2019) -
Comparison of Hematopoietic Stem Cell Transplantation Outcomes Using Matched Sibling Donors, Haploidentical Donors, and Immunosuppressive Therapy for Patients With Acquired Aplastic Anemia
por: Zhang, Yuanfeng, et al.
Publicado: (2022) -
Co-transplantation of mesenchymal stem cells makes haploidentical HSCT a potential comparable therapy with matched sibling donor HSCT for patients with severe aplastic anemia
por: Liu, Zenghui, et al.
Publicado: (2020) -
Comparable Outcomes in Acquired Severe Aplastic Anemia Patients With Haploidentical Donor or Matched Related Donor Transplantation: A Retrospective Single-Center Experience
por: Wang, QingYun, et al.
Publicado: (2022)